Study guide
5.5 Endovascular Aortic Repair: EVAR and TEVAR
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
5.5 Endovascular Aortic Repair: EVAR and TEVAR
Key Takeaways Explain This Topic AI
Elective repair thresholds are roughly 5.5 cm for an infrarenal abdominal aortic aneurysm in men and about 5.0 cm in women, about 5.5-6.0 cm for a descending thoracic aneurysm, growth greater than 0.5 cm in 6 months or 1.0 cm in a year, or symptoms at any size.
Type I (seal-zone) and type III (component separation or fabric tear) endoleaks pressurize the aneurysm sac at systemic pressure and require prompt intervention; type II branch backflow is observed unless the sac enlarges, type IV porosity needs no treatment, and type V is expansion with no demonstrable leak.
Spinal cord perfusion pressure equals mean arterial pressure minus cerebrospinal fluid pressure, so spinal cord ischemia after TEVAR is treated by raising MAP toward 90-100 mmHg and draining CSF to an intrathecal pressure near 10 mmHg (often 5 mmHg once a deficit appears).
Post-implantation syndrome is fever, leukocytosis and elevated CRP within 24-72 hours in a well-appearing patient with negative cultures; it is self-limited and is not treated with antibiotics, unlike graft infection.
After TEVAR the pressure targets compete — low to protect the seal zone, high to perfuse the cord — and the priority rule is that a new lower-extremity motor deficit means the MAP goes up, not down, and the provider is notified immediately.
Last updated: August 2026
What Endovascular Aortic Repair Is, and Who Qualifies
EVAR (endovascular aneurysm repair) places a covered stent-graft inside an infrarenal abdominal aortic aneurysm through bilateral femoral access, excluding the aneurysm sac from arterial pressure while blood flows through the fabric lumen. TEVAR (thoracic endovascular aortic repair) does the same in the descending thoracic aorta. Neither operation removes the aneurysm — the sac is still there, and it will still rupture if it becomes repressurized. That single fact explains everything about endoleaks and about lifelong surveillance, and it is the concept the CMC exam is really testing.
Anatomic Criteria — Why Not Every Aneurysm Is a Candidate
The device needs a landing zone of healthy aorta above and below the aneurysm to seal against.
Proximal neck length — generally at least 10-15 mm of non-aneurysmal infrarenal aorta below the lowest renal artery.
Neck angulation — severe angulation (roughly beyond 60 degrees) prevents wall apposition and predisposes to type I endoleak and graft migration.
Neck diameter, thrombus and calcium burden — a wide, thrombus-lined or heavily calcified neck seals poorly.
Iliofemoral access — the vessels must accept a 14-24 French delivery system without being too small, too calcified or too tortuous. When they will not, a surgical iliac conduit or an iliac branch device is used.
When the aneurysm involves the renal or visceral segment, fenestrated (FEVAR) and branched (BEVAR) devices with custom holes or side branches preserve flow to the renal, superior mesenteric and celiac arteries. These are longer cases with far more contrast, higher renal risk, and higher spinal cord ischemia risk than a standard infrarenal EVAR — an important nursing distinction when the handoff simply says "the patient had a stent graft."
Size Thresholds and Indications
- Lesion Threshold for elective repair
- Infrarenal abdominal aortic aneurysm, men 5.5 cm or larger
- Infrarenal abdominal aortic aneurysm, women approximately 5.0 cm
- Rapid growth, any abdominal aortic aneurysm more than 0.5 cm in 6 months or more than 1.0 cm in 12 months
- Symptomatic or ruptured aneurysm any size — emergency
Descending thoracic aortic aneurysm approximately 5.5-6.0 cm; lower in heritable connective tissue disease at experienced centers
Complicated acute type B dissection (malperfusion, rupture, refractory pain or refractory hypertension) TEVAR is first-line therapy
Uncomplicated acute type B dissection with high-risk features TEVAR is increasingly offered in the subacute window to prevent late aneurysmal degeneration
A post-EVAR patient often looks better than a post-cholecystectomy patient: two small groin punctures, out of bed the same day, an ICU stay measured in hours. That deceptive appearance is exactly why the exam tests complication recognition — the catastrophes are silent until they are not.
Endoleaks: The Defining Complication
An endoleak is persistent blood flow into the aneurysm sac outside the graft lumen. Because the sac was never removed, an endoleak means the sac may still be pressurized and can still rupture.
Type Mechanism Pressure and urgency Management
I (Ia proximal, Ib distal) Inadequate seal at an attachment site — the graft fails to appose the aortic or iliac wall Systemic pressure. Urgent Prompt repair: balloon molding, proximal cuff or iliac extension, endoanchors, or open conversion
II Retrograde backflow from branch vessels — lumbar arteries, inferior mesenteric artery, accessory renal artery, or intercostal/subclavian branches after TEVAR Low pressure. The most common type (up to roughly 25%); many seal spontaneously Surveillance if the sac is stable; coil or glue embolization if the sac enlarges
III (IIIa junctional, IIIb fabric tear) Separation between modular graft components, or a hole in the graft fabric Systemic pressure. Urgent Relining with a bridging component
IV Porosity of the graft fabric itself Self-limited; essentially historical with modern low-porosity fabrics No treatment
V (endotension) Sac expansion with no leak demonstrable on imaging An expanding sac is a rupture risk regardless of cause Treat ongoing expansion; may require relining or conversion
Memory hook: I and III are high-pressure and get fixed. II is watched. IV is a non-event. V is expansion without an explanation.
Surveillance
CT angiography is the surveillance standard — typically at 1 month, at 12 months, and annually thereafter, with duplex or contrast-enhanced ultrasound substituted at some intervals in renal impairment. A non-contrast CT shows sac diameter but will not show the leak. The teaching point the exam rewards: the patient must return for imaging for the rest of their life, even feeling perfectly well. Missed surveillance is how an unrecognized type I endoleak becomes a rupture years later.
Other Graft-Related Complications
Graft migration — caudal movement out of the proximal seal zone, which then produces a type Ia endoleak.
Graft limb occlusion or kinking — presents as new unilateral claudication or a cool, pulseless leg in the first days to weeks. Compare limbs at every assessment; a graft limb thromboses silently in a patient who is comfortable in bed.
Access-site complications — hematoma, pseudoaneurysm, dissection, and limb ischemia from 14-24 French sheaths. Percutaneous closure device failure is more consequential here than after coronary work purely because of sheath caliber.
Contrast-associated acute kidney injury and renal infarction — from a heavy contrast load plus suprarenal fixation barbs or inadvertent coverage of an accessory renal artery. Trend creatinine and urine output and document the contrast dose.
Aortoenteric or aortobronchial fistula — late, rare and catastrophic. A "herald" gastrointestinal bleed or hemoptysis in any patient with an aortic graft is a fistula until proven otherwise.
Stroke and left upper-limb ischemia after TEVAR when the left subclavian artery is covered without revascularization. Assess left arm pulses and blood pressure, left arm claudication, and posterior circulation symptoms such as vertigo, diplopia and ataxia.
Retrograde type A dissection after TEVAR — new severe chest or interscapular pain with hemodynamic change, a new murmur, or a pulse/blood pressure differential between arms.